Review
Oct 2026
Clinical trial designs in the era of biomarker-guided therapies.
Julien Rousseau, M. J. van den Bent, Patrick Y. Wen
· Neuro-Oncology · 0 citations
We have 3 of 945 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Open access
Aug 2026
CLTR-02 OUTCOMES OF SURGICAL RESECTION IN PATIENTS WITH MORE THAN ONE BRAIN METASTASIS
Surgical resection in selected patients with multiple BMs in a good clinical condition provides a meaningful OS and iPFS, possibly by creating a window of opportunity for SRT and systemic therapies.
Micha van der Lee, Miles E. Dijkstra, S. Derks et al.
· Neuro-Oncology Advances · 0 citations
Review
Aug 2026
Exploring the landscape of targetable alterations in patients with glioblastoma.
The therapeutic landscape of targeted therapies in glioblastomas is summarized, spanning major target classes including receptor tyrosine kinases, intracellular signalling proteins, cell-cycle dysregulation and synthetic-lethal vulnerabilities and emerging strategies targeting genome integrity and telomeres, epigenetic...
E. Aquilanti, M. Touat, P. French et al.
· Nature Reviews Clinical Onco... · 0 citations